SensoDetect continues to develop the SensoDetect Medical Advisory Board with prominent Dr Saleh (Saudi Arabia) and Dr Löfström (Sweden)
As a gateway for the continued work in SensoDetect addressing medical issues, writing, and reviewing educational materials, establish research funding, identify fundraising opportunities and act as prominent ambassadors worldwide for the SensoDetect's method, the company has appointed expert Medical Doctors, Dr Saleh of Saudi Arabia and Dr Löfström of Sweden as medical advisors.
"Our advisory board provides strategic advice and expertise to all situations in our organization. As experienced and trusted advisors they will support our vision and guide SensoDetect in the right direction. As our goal is to advance health equity in part through expanding our offer, our method and provide access to people, all people wherever they live, it’s critical to achieve a transformation in different geographical areas with advancement in technology and to capitalize on knowledge from inside to outside of the company. To ensure this our medical advisory board will apply their knowledge in a way that protects patient health in a wider perspective while continuing to support innovation of our invention and method", says CEO Per-Anders (PA) Hedin.
About our Medicinal Advisory Board.
Dr. Löfström has authored 40 published papers and clinical works. He initially conducted brain research at the Karolinska Institute in Stockholm, where he earned his PhD in 1977. Dr. Löfström received his medical and clinical training at the University hospitals in Lund and Malmö, obtaining his MD in 1986 and becoming a specialist in Child and Youth Psychiatry in 1991. He studied analytical psychology at the Jung Institute in Küsnacht, Switzerland, near Zürich, during the following years. Soon after he started his own psychiatric clinic in Lund, where he has been working with the diagnosis and treatment of neuropsychiatric conditions such as ADHD and, more recently, autism.
Dr. Saleh is a seasoned healthcare leader with extensive experience in health system operations and hospital transformation. He has a distinguished track record in establishing and leading healthcare services at various levels, from primary to tertiary care, across different regions in Saudi Arabia. Dr. Saleh serves as a member of the Prince Mohammed Bin Salman Autism Program Development Scientific Committee at Armed Forces Health Services, where he is responsible for healthcare services aligned with Saudi Vision 2030. He is also a Clinical Assistant Professor at Princess Nourah Bint Abdulrahman University (PNU) School of Medicine and has academic affiliations with King Saud University and King Saud bin Abdulaziz University for Health Sciences.
As the founder and Director of the Child Health Excellence Center at King Abdullah Bin Abdulaziz University Hospital (KAAUH) at PNU, Dr. Saleh plays a pivotal role in advancing pediatric healthcare. He is a CBAHI Hospital Surveyor and contributed to the 2022 revision of the V4 hospital leadership and quality chapter. Additionally, he is the STL for home healthcare, a member of the Autism Services Accreditation Program Committee, and the Chairman of the National Developmental Disorders Scientific Committee under the Saudi Health Council (SHC). Dr. Saleh also chairs the newly established SCFHS fellowship in developmental and behavioral pediatrics and the National Autism Registry Scientific Committee. Furthermore, he founded Ruaa Home Health Care Service, enhancing healthcare access and quality for patients at home.
För ytterligare information, vänligen kontakta:
PA Hedin, VD Sensodetect AB
+46 (0)73-068 64 20
pa.hedin@sensodetect.com
SensoDetect AB är ett Med Tech AI-företag noterat på Spotlight stock market. Företaget grundades i Lund 2005, baserat på mer än 30 års forskning inom klinisk psyko akustik vid Institutionen för Neurovetenskap vid Lunds universitet. Inledningsvis låg fokus på patienter med schizofreni, då det är en sjukdom där hörselhallucinationer är ett vanligt symtom, men idag erbjuder företaget ett flertal andra tjänster inom produktområdena diagnostik, medicinering och hälsa. Produkterna används inom både privat och offentlig vård som komplement till andra observationer vid ADHD, schizofreni och autismutredningar, vid mätning av läkemedelseffekt samt vid screening av hörsel. SensoDetects unika och globalt patenterade teknik minskar den ekonomiska påverkan på hälso- och sjukvården samt samhället och ger patienter och dess anhöriga ett snabbare och säkrare resultat.
Mer info på https://www.sensodetect.com/